Z. Li

Efficacy and safety of mitiglinide versus nateglinide in newly diagnose patients with type 2 diabetes mellitus: a randomized double blind trial

Gangyi Yang, L. Li, G. Yang, 2012, Diabetes, obesity & metabolism.

Ambroxol as a novel disease-modifying treatment for Parkinson’s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial

Penny A. MacDonald, R. Bartha, M. Borrie, 2019, BMC Neurology.